BIOCOM for BIOCOM
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Advocated for passage of FDA User Fee legislation Advocated for the Cures 2.0 Act Advocated to raise concerns about CMS proposed National Coverage Decision on Amyloid-directed Monoclonal Antibodies for the Treatment of Alzheimers Disease Submitted Comments to Congress on Wearable Technology Submitted Comments to OSTP on Digital Health Technology Submitted Comments to FDA regarding EUA transition of medical devices Submitted Comments to CMS proposed National Coverage Decision on Amyloid-directed Monoclonal Antibodies for the Treatment of Alzheimers Disease Hosted a webinar on the Prescription Drug User Fee Act (PDUFA) Hosted a webinar on the CMS National Coverage Decision on Amyloid-directed Monoclonal Antibodies for the Treatment of Alzheimers Disease Hosted a webinar on the Cures 2.0 Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
| RICHARD WHITE New | — |
Copyright/Patent/Trademark CPT
Advocated for the protection of Intellectual Property rights Advocated for protection of the Bayh-Dole Act and against using march-in provisions to control drug pricing Expressed opposition to the Administration's decision to support waiving IP protections for covid-19 vaccines under the TRIPS agreement.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
| RICHARD WHITE New | — |
Taxation/Internal Revenue Code TAX
Authored a letter to Congress to protect the Orphan Drug Tax Credit Advocated to reverse a tax provision preventing businesses from deducting their R&D expenses in the same year they were incurred
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
| RICHARD WHITE | — |
Trade (domestic/foreign) TRD
Advocated for strengthening the US supply chain and mitigating supply chain disruptions of essential products
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
| RICHARD WHITE New | — |
Budget/Appropriations BUD
Advocated for increased discretionary funding for R&D at government research institutions
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK New | — |
| RICHARD WHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.